SA
CRMD icon

Sanctuary Advisors’s CorMedix CRMD Stock Holding History

Sanctuary Advisors’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$135K Buy
17,246
+104
+0.6% +$822 ﹤0.01% 2683
2026
Q1 		$116K Sell
17,142
-117,527
-87% -$869K ﹤0.01% 2442
2025
Q4 		$1.57M Buy
134,669
+122,961
+1,050% +$1.36M 0.01% 1067
2025
Q3 		$136K Buy
11,708
+182
+2% +$2.2K ﹤0.01% 2316
2025
Q2 		$142K Sell
11,526
-7,671
-40% -$84.7K ﹤0.01% 2228
2025
Q1 		$118K Sell
19,197
-54
-0.3% -$559 ﹤0.01% 2098
2024
Q4 		$211K Buy
19,251
+7
+0% +$70 ﹤0.01% 2219
2024
Q3 		$192K Sell
19,244
-12,649
-40% -$68.5K ﹤0.01% 2236
2024
Q2 		$169K Buy
+31,893
New +$162K ﹤0.01% 2206

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Sanctuary Advisors's CRMD Position: Q2 2026 in Review

Sanctuary Advisors increased its CorMedix (CRMD) stake by 0.61% in Q2 2026, buying an estimated $822 and bringing the position to 17,246 shares worth $135K. The position accounts for ﹤0.01% of the portfolio, ranked #2683.

Sanctuary Advisors first reported a position in CRMD in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.57M in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Sanctuary Advisors held 17,246 shares of CorMedix worth $135K as of Q2 2026.
  • Sanctuary Advisors bought 104 CorMedix shares in Q2 2026, an estimated $822.
  • CorMedix made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #2683 holding.
  • Sanctuary Advisors first reported a position in CorMedix in Q2 2024 and has held it in 9 quarters since.
  • Sanctuary Advisors's CorMedix position peaked at $1.57M in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.